#GFN25 Science Discussion #8 | The Next Frontier in Advancing THR: Oral Nicotine Products

Discover how oral nicotine pouches could represent the next frontier in tobacco harm reduction, with a deep dive into their chemistry, toxicology, and real-world use data compared with cigarettes and traditional snus. In this Science Lab session, Chris presents new evidence on toxicant reduction, biomarkers of exposure and potential harm, pharmacokinetics, and user behavior across different markets, followed by an engaging Q&A on addiction, product satisfaction, and study design.